31.10.2016 • NewsDede WillamsChinaUBE

Ube and Mitsubishi Plan Chinese Battery JV

(c) Predrag Novakovic/iStockphoto
(c) Predrag Novakovic/iStockphoto

Two Japanese companies, Ube Industries and Mitsubishi Chemical, have agreed to combine their electrolyte businesses in China in a 50:50 joint venture. The deal aimed at enhancing technology and improving costs will take effect from April 2017 if approved by state authorities in China and other relevant countries. Ube and Mitsubishi said they may later consider extending the business, which supplies the lithium-ion batteries market, to other countries.

Ube Industries manufactures electrolytes at its Sakai plant n Osaka Prefecture, Japan, and at a plant located in Zhangjiagang, Jiangsu Province, China. Annual production capacity totals 10,000 t/y in Japan and 5,000 t/y in China. Mitsubishi’s production facilities are located at Yokkaichi in Mie Prefecture, Japan, Stockton-on-Tees, UK,  Memphis, Tennessee, USA, and Changshu, Jiangsu, China. The company’s Japanese output runs to 13,500 t/y, with 10,000 t/y produced in the UK, US and China.

Driven by government subsidies, the market for lithium-ion batteries used in automobiles is growing rapidly in China, Demand for battery materials including electrolytes is also sharply increasing, amid an increasingly competitive market, the future joint venture partners said.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.